GlassScriptPhysician profile
Christopher D Morris
NPI 1083718373
$6,439.21
in general payments reported to CMS, 2019-2025
23 companies · $1,112 in 2025
The $1,112 reported for 2025 was more than what 92% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,171 · 2020: $111 · 2021: $668 · 2022: $1,218 · 2023: $710 · 2024: $451 · 2025: $1,112.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,235 · Entertainment: $18.50 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,235.42 |
| Entertainment | $18.50 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lombart Brothers, INC. | $1,593.84 | 2019-2025 | Opd-III |
| Bausch & Lomb Americas INC. | $936.51 | 2022-2025 | Infuse, Infuse Multifocal, Miebo |
| Coopervision INC. | $803.98 | 2019-2025 | Myday Contact Lens |
| Alcon Vision LLC | $682.96 | 2019-2025 | Precision7, Dailies Total1, Total30 |
| Glaukos Corporation | $509.91 | 2022-2025 | Photrexa Viscous and Photrexa |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $454.00 | 2019-2021 | |
| Abbvie INC. | $231.31 | 2022-2025 | |
| Maculogix, INC. | $166.78 | 2021 | |
| Optos, INC. | $163.56 | 2021-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Lkc Technologies, INC. | $142.43 | 2025 | |
| Novartis Pharmaceuticals Corporation | $140.98 | 2022 | |
| Horizon Therapeutics Plc | $97.95 | 2022 | |
| Topcon Healthcare, INC. | $88.39 | 2025 | |
| Johnson & Johnson Vision Care, INC. | $69.37 | 2022-2024 | Acuvue |
| Carl Zeiss Meditec USA, INC. | $67.05 | 2023 | Clarus |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abb Con-Cise Optical Group LLC | $65.92 | 2024 | Contact Lens, Spectacle Lenses |
| Tarsus Pharmaceuticals, INC. | $57.79 | 2025 | Xdemvy |
| Biotissue Holdings INC. | $47.16 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $31.28 | 2019 | |
| Lumibird Medical INC. | $23.08 | 2021 | |
| Kala Pharmaceuticals, INC. | $22.87 | 2021 | |
| Allergan, INC. | $22.38 | 2022 | |
| Sumitomo Pharma America, INC. | $19.71 | 2024 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.